UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION

Informazioni relative al progetto

CLOSPORE

ID dell’accordo di sovvenzione: 642068

DOI

10.3030/642068

Progetto chiuso

Data della firma CE 16 Dicembre 2014

Data di avvio 1 Gennaio 2015

Data di completamento 31 Dicembre 2018

Finanziato da

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Costo totale

€ 3 910 777,56

Contributo UE

€ 3 910 777,56

Coordinato da

THE UNIVERSITY OF NOTTINGHAM
United Kingdom

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Other (20)

Sporulation Mutants Isolated

Directed random from Clostridium sp

Germination Mutants Isolated

Directed random from Clostridium sp

Increased understanding of disease

Improved epidemiology/ diagnostics

Characterised sporulation genes

Role of sporulation genes determined

ESRs recruited

Target date for all starters

First ESR scientific presentation

Given at nationalinternational meeting

Appointment of Supervisory Board

Supervisory Board committee members selected

Conditionally CDEPTsporulating strain

Prototype strain for clinical trial

Decision-making at single cell level

Understanding sporulationtoxigenesis

Ethics

Delivery of ethics documents before commencement of the relevant part of the research

Exemplification of ACE technology

Demonstrated in target Clostridium sp

Characterised germination genes

Role of germination genes determined

Promotional material distributed

Webdownloads and meeting flyers

Mid-term Conference

Conference Proceedings at website

Submission of Doctorate Thesis

Subject to National requirements

Universal transposon exemplified

Exemplified in target Clostridium

Final Conference Proceedings

Conference Proceedings at website

Spore regulators common to toxins

Links to toxin/metabolite production

New sporulation/germination genes

In pathogenic nonpathogenic clostridia

Asporogenous butanol producers

In C acetobutylicum Clostridium sp

Documents, reports (1)

Final Report

Final Project report submitted to commission

Websites, patent fillings, videos etc. (2)

Social Media Established

Twitter account Facebook Page active

CLOSPORE website

Website established at wwwclosporenet

Pubblicazioni

Peer reviewed articles (5)

Hijacking CRISPR-Cas for high-throughput bacterial metabolic engineering: advances and prospects

Autori: Ioannis Mougiakos, Elleke F Bosma, Joyshree Ganguly, John van der Oost, Richard van Kranenburg
Pubblicato in: Current Opinion in Biotechnology, Numero 50, 2018, Pagina/e 146-157, ISSN 0958-1669
Editore: Elsevier BV
DOI: 10.1016/j.copbio.2018.01.002

Investigating the Central Metabolism of Clostridium thermosuccinogenes

Autori: Jeroen Girwar Koendjbiharie, Kilian Wiersma, Richard van Kranenburg
Pubblicato in: Applied and Environmental Microbiology, Numero 84/13, 2018, Pagina/e e00363-18, ISSN 0099-2240
Editore: American Society for Microbiology
DOI: 10.1128/AEM.00363-18

L-Rhamnose metabolism in Clostridium beijerinckii DSM 6423

Autori: M. Diallo, A. D. Simons, H. van der Wal, F. Collas, Bwee Houweling-Tan, S. W. M. Kengen, A. M. López-Contreras
Pubblicato in: Applied and Environmental Microbiology, 2018, ISSN 0099-2240
Editore: American Society for Microbiology
DOI: 10.1128/aem.02656-18

Generation of a fully erythromycin-sensitive strain of Clostridioides difficile using a novel CRISPR-Cas9 genome editing system

Autori: Patrick Ingle, Daphne Groothuis, Peter Rowe, He Huang, Alan Cockayne, Sarah A. Kuehne, Weihong Jiang, Yang Gu, Christopher M. Humphreys, Nigel P. Minton
Pubblicato in: Scientific Reports, Numero 9/1, 2019, ISSN 2045-2322
Editore: Nature Publishing Group
DOI: 10.1038/s41598-019-44458-y

RiboCas: A Universal CRISPR-Based Editing Tool for Clostridium

Autori: Inés C. Cañadas, Daphne Groothuis, Maria Zygouropoulou, Raquel Rodrigues, Nigel P. Minton
Pubblicato in: ACS Synthetic Biology, 2019, ISSN 2161-5063
Editore: American Chemical Society
DOI: 10.1021/acssynbio.9b00075

Diritti di proprietà intellettuale

Patent (1)

PROCESSES INVOLVING CLOSTRIDIUM SACCHAROPERBUTYLACETONICUM

Numero candidatura/pubblicazione: PCT/ GB2018/052937
Data: 2018-10-12
Candidato/i: BIOCLEAVE LIMITED